scispace - formally typeset
F

Francesca Clementina Radio

Researcher at Boston Children's Hospital

Publications -  70
Citations -  820

Francesca Clementina Radio is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 13, co-authored 50 publications receiving 456 citations. Previous affiliations of Francesca Clementina Radio include Sapienza University of Rome & Casa Sollievo della Sofferenza.

Papers
More filters
Journal ArticleDOI

Histone H3.3 beyond cancer: Germline mutations in Histone 3 Family 3A and 3B cause a previously unidentified neurodegenerative disorder in 46 patients

Laura M Bryant, +146 more
- 02 Dec 2020 - 
TL;DR: Patient histone posttranslational modifications (PTMs) analysis revealed notably aberrant local PTM patterns distinct from the somatic lysine mutations that cause global PTM dysregulation, suggesting that the mechanism of germline mutations are distinct from cancer-associated somatic histone mutations but may converge on control of cell proliferation.
Journal ArticleDOI

Aberrant Function of the C-Terminal Tail of HIST1H1E Accelerates Cellular Senescence and Causes Premature Aging.

Elisabetta Flex, +68 more
TL;DR: This work identifies a direct link between aberrant chromatin remodeling, cellular senescence, and accelerated aging in germline frameshift mutations involving the C-terminal tail of HIST1H1E.
Journal ArticleDOI

A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin-associated iron overload diseases

TL;DR: Findings confirm that certain ferroportin mutations compromise the activity of hepcidin in iron homeostasis, mimicking hePCidin deficiency as described in all types of hemochromatosis.
Journal ArticleDOI

Enhanced MAPK1 Function Causes a Neurodevelopmental Disorder within the RASopathy Clinical Spectrum

Marialetizia Motta, +51 more
TL;DR: The data support a model in which the identified pathogenic variants operate with counteracting effects on MAPK1 function by differentially impacting the ability of the kinase to interact with regulators and substrates, which likely explains the minor role of these variants as driver events contributing to oncogenesis.